Tai Zi Shen

Pseudostellaria heterophylla (Miq.) Pax ex Pax et Hoffm.

Also known as: Pseudostellaria root(English) 太子参(Chinese)

T'ai Tzŭ Shên

Updated October 5, 2026 · Not yet clinically reviewed

Tai Zi Shen
Photo: Qwert1234, CC BY-SA 4.0, via Wikimedia Commons

Safety at a glance

Note

3 recorded drug interactions

Note

Contraindications or side effects are listed

No rule in our tables for this herb: pregnancy, breastfeeding, incompatible pairs (十八反 / 十九畏), herb–drug, dose ceiling. This is not a safety clearance.
Not graded —

No toxicity grade is recorded. Most herbs in the catalogue carry none.

Traditional Chinese Medicine

Category
tonifying
Temperature
Neutral
Taste
Sweet,Bitter
Channels
Spleen,Lung

Functions

Tonifies Qi and Strengthens the Spleen; Generates Fluids; Moistens the Lungs; Benefits the Stomach and Generates Fluids; Benefits Qi and Nourishes Yin

Traditional uses

Tai Zi Shen (pseudostellaria root, prince ginseng) is a cool, mild Qi and Yin tonic that supplements both Spleen Qi and Lung Yin without the warming intensity of larger ginsengs. It is used for fatigue, poor appetite, and digestive weakness from Spleen Qi deficiency, as well as for dry cough and thirst from Lung Yin deficiency. Its gentle cooling-tonic nature makes it particularly suitable for children, the elderly, those with heat-sensitive constitutions, and anyone recovering from illness who needs mild Qi and Yin support.

Western herbalism

Properties: tonic

Formulas using this herb

2 of 2 formulas

Botanical

Pseudostellaria heterophylla (Caryophyllaceae), known as Tai Zi Shen or prince's ginseng, is a small perennial herb 15-20 cm tall arising from a slender, fleshy, spindle-shaped tuberous root 2-7 cm long. The slender stems bear opposite, sessile, lanceolate to elliptic leaves; uppermost stem leaves are typically larger and crowded into a pseudo-whorl of four. White, five-petaled chasmogamous flowers appear in spring on long pedicels from upper leaf axils, while cleistogamous flowers form near the base for self-pollination. Native to cool, shaded mountain woodlands of eastern China, Korea, and Japan. The tuberous roots are dug in summer when foliage withers, briefly scalded, and sun-dried into pale yellowish-white, slightly translucent rods. (Sources: POWO; Wikipedia; Bensky)

Family
Caryophyllaceae
Pharmaceutical name
Radix Pseudostellariae
Parts used
root
Plant type
herb

Constituents

Heterophyllin B

Caryophyllaceae-type cyclic octapeptide · roughly 0.011-0.036% of the dried tuberous root, varying by production area (lowest in Guizhou material, highest in Anhui and Jiangsu material)

The best-studied marker compound of the drug and the compound most often used to grade it. It is brain-permeable in mice and has been shown to reduce IL-6, IL-1beta and TNF-alpha release, to reverse amyloid-beta-induced axonal atrophy in cultured cortical neurons, and to improve memory retrieval in intracerebroventricular amyloid-beta mouse models. It is poorly water-soluble, has low oral bioavailability and is subject to P-glycoprotein efflux, so systemic exposure from a decoction is likely to be modest.

Heterophyllin A

Caryophyllaceae-type cyclic peptide

A companion cyclopeptide to heterophyllin B, co-accumulating with it in the tuberous root and used alongside it and pseudostellarin G in quality grading of the drug. Its own pharmacology is much less characterised than that of heterophyllin B.

Pseudostellarins A-H, K and L

Cyclic peptides (penta- to decapeptides)

A second family of cyclopeptides from the tuberous root, ranging from pentapeptides to decapeptides. Reported activities include tyrosinase inhibition and suppression of melanin synthesis. Several pseudostellarins are among the metabolites that distinguish material from different Chinese provinces.

Pseudostellaria heterophylla polysaccharides (including the branched alpha-glucan PF30-3)

Polysaccharide · total polysaccharides roughly 10.1-25.1% of the dried root depending on production area, with some selected cultivars assayed considerably higher

Quantitatively the largest bioactive fraction. PF30-3 is a homogeneous branched alpha-D-glucan of about 69.9 kDa with a (1 to 4)-alpha-D-glucopyranosyl backbone and (1 to 4,6) branch points; a separate preparation of about 8.8 kDa was composed mainly of glucose and galactose. These fractions are immunomodulatory in macrophage and animal models, hypoglycaemic, antioxidant, and act partly through the gut microbiota rather than by direct systemic absorption.

Triterpenoid saponins (total saponins)

Triterpenoid saponin · reported up to roughly 2.8% of the dried root in the highest-scoring cultivars in varietal screening trials

Assayed as one of the routine quality indicators for the drug alongside polysaccharides and heterophyllin B. Individual saponins are poorly characterised and most reported pharmacology for this herb belongs to the cyclopeptide and polysaccharide fractions rather than to the saponins.

Drug interactions

P-glycoprotein substrates and P-glycoprotein inhibitors (e.g. verapamil, ciclosporin, digoxin)

Theoretical · Direction of effect unknown; a P-gp inhibitor could raise systemic exposure to heterophyllin B, and the reverse effect on co-administered P-gp substrates has not been tested · Evidence level: Theoretical

Heterophyllin B was shown to be susceptible to P-glycoprotein efflux, which is one reason its oral bioavailability is low enough that a targeted delivery system was developed for it. That establishes the herb's marker compound as a P-gp substrate but says nothing about whether the herb inhibits or induces the transporter, and no P-gp interaction study on the whole drug has been published.

Clinical note: No action needed on this basis alone. Flagged only so that unexpectedly strong or weak effects in a patient on a P-gp-modulating drug are not mistaken for something else.

Oral hypoglycaemic agents and insulin

Theoretical · Possible additive glucose lowering · Evidence level: Theoretical

Both the polysaccharide fraction and heterophyllin B have hypoglycaemic and insulin-sensitising activity in rodent models, with heterophyllin B acting on hepatic IRS2/PI3K-Akt/FoxO1 signalling in a type 2 diabetes model. No human pharmacodynamic or interaction data exist, and effect sizes at decoction doses are unknown.

Clinical note: Tai Zi Shen is a mild tonic and this is a low-concern interaction, but a diabetic patient starting a long course containing it can reasonably be asked to keep monitoring glucose as usual.

Immunosuppressants (e.g. ciclosporin, tacrolimus, azathioprine)

Theoretical · Theoretical opposition of intended immunosuppression · Evidence level: Theoretical

The polysaccharide fraction is immunostimulatory in vitro and in vivo: dietary supplementation raised specific antibody titres, immune organ indices and serum IgG, IL-4, IL-6 and IFN-gamma in vaccinated chicks, and macrophage assays show cytokine modulation. Whether this translates to any measurable interference with therapeutic immunosuppression in humans is entirely untested.

Clinical note: Mention it to transplant and autoimmune patients as an unquantified theoretical concern rather than a reason to withhold the herb; there are no case reports of graft dysfunction attributed to this drug.

Dosage

FormAmountFrequencyNotes
decoction9–30 gDaily
中国药典 2020 【用法与用量】9~30g。 【性味与归经】甘、微苦,平。归脾、肺经。 — Chinese Pharmacopoeia 2020, quoted verbatim; route and cautions preserved. Replaces a cleared category-filler value.

Evidence

Study design on record, not certainty of outcome.

In vitro / animal
6

Heterophyllin B, a cyclopeptide from Pseudostellaria heterophylla, improves memory via immunomodulation and neurite regeneration in i.c.v.Aβ-induced mice

Deng J, Feng X, Zhou L, He C, Li H, Xia J, Ge Y, Zhao Y, Song C, Chen L, Yang Z · Food Research International · 2022 · animal

In vitro / animal · Verified

Heterophyllin B was shown to cross into the brain, and both the whole Pseudostellaria heterophylla extract and the isolated cyclopeptide reversed amyloid-beta-25-35-induced axonal atrophy and neuronal apoptosis in cultured mouse cortical neurons. In mice given intracerebroventricular amyloid-beta-1-42, heterophyllin B improved memory retrieval, modulated splenic T helper cell populations and reduced neuroinflammation. Network pharmacology identified five candidate targets linked to axonal regeneration.

doi:10.1016/j.foodres.2022.111576

Pseudostellaria heterophylla polysaccharide mitigates Alzheimer's-like pathology via regulating the microbiota-gut-brain axis in 5 × FAD mice

He C, Jiang J, Liu J, Zhou L, Ge Y, Yang Z · International Journal of Biological Macromolecules · 2024 · animal

In vitro / animal · Verified

A characterised polysaccharide fraction of about 8.8 kDa, composed of glucose (about 58%), galactose (about 42%) and a trace of arabinose, improved learning and spatial memory, reduced amyloid-beta accumulation and suppressed reactive glia and astrocytes in 5xFAD transgenic mice. 16S rRNA sequencing showed the polysaccharide remodelled the gut flora, promoting Lactobacillus, Muribaculum and related taxa, which the authors argue is the route of the central effect since a polysaccharide of this size is not appreciably absorbed.

doi:10.1016/j.ijbiomac.2024.132372

Structural characterization of a branched α-glucan from Pseudostellaria heterophylla and its neuroprotective effect against Alzheimer's disease via regulating the microbiota-gut-brain axis

Chen L, Kang X, Deng W, Zhang Y, Zhao Y, Song C, Yang Z · International Journal of Biological Macromolecules · 2026 · animal

In vitro / animal · Verified

PF30-3, a homogeneous branched alpha-D-glucan of 69.91 kDa, inhibited nitric oxide release and rebalanced inflammatory cytokines in lipopolysaccharide-stimulated RAW264.7 macrophages at 200 micrograms/mL. It rescued spatial memory in an amyloid-beta-1-42 zebrafish model at 20 mg/kg, and 50 mg/kg orally for 24 days improved recognition and spatial memory in 5xFAD mice with reduced cerebral amyloid-beta deposition and no observable acute toxicity.

doi:10.1016/j.ijbiomac.2026.153352

The effects of pseudostellaria heterophylla polysaccharide on humoral immunity and gene expression of splenic lymphocytes in chicks

Wang B, Wang X, Li X, Zhu Y, Meng Q, Zhu Z, Guo Y, Tian Y, Jiang R, Sun G, Han R, Kang X, Mei C, Yan F · Developmental and Comparative Immunology · 2025 · animal

In vitro / animal · Verified

270 chicks were assigned to unvaccinated control, vaccinated control, or vaccinated plus 200 mg/kg dietary polysaccharide. The polysaccharide group had higher specific antibody titres after the first immunisation, higher spleen and bursa indices at day 35, and higher serum IgG, C3, IL-4, IL-6 and IFN-gamma than vaccinated controls, with upregulation of immune-related genes in splenic lymphocytes. This is the clearest in vivo evidence that the polysaccharide fraction is an immune adjuvant rather than merely immunomodulatory in vitro.

doi:10.1016/j.dci.2025.105450

Heterophyllin B ameliorates diabetic lower limb ischemia by inhibiting SMOX to activate the Nrf2 antioxidant pathway

Lin S, Huang Y, Wang Y, Xue Y, Lou S, Wang Q, Wang Y, Lu Y, Wu J, Zhang S, Yin H, Zhang T, Li L, Zhang L · Chinese Medicine · 2026 · animal

In vitro / animal · Not yet verified

In streptozotocin-diabetic mice given femoral artery ligation, heterophyllin B improved limb perfusion and endothelial function; in high-glucose-exposed human umbilical vein endothelial cells it restored tube formation, migration and wound healing. The effect was traced to inhibition of spermine oxidase with consequent Nrf2 antioxidant pathway activation, confirmed by SMOX silencing and spermine challenge.

doi:10.1186/s13020-026-01440-x

Pseudostellaria heterophylla polysaccharides attenuate diabetic lower limb ischemia via CYP2E1-mediated mitochondrial homeostasis and PANoptosis regulation

Wang Y, Tao Y, Zhang S, Wang Q, Liu Z, Lin S, Wang Y, Huang Y, Zhang T, Mayala HA, He W, Shen H, Zhang L, Chai H · Phytomedicine · 2025 · animal

In vitro / animal · Not yet verified

The polysaccharide fraction improved blood perfusion and microvessel density in a murine diabetic lower limb ischaemia model and restored migration, proliferation and tube formation in high-glucose-treated human umbilical vein endothelial cells, acting through CYP2E1-linked mitochondrial homeostasis and suppression of PANoptosome assembly.

doi:10.1016/j.phymed.2025.157252

Safety

Contraindications

It is not suitable for patients with exterior excess pattern and exuberance of pathogens.

Source: Xi S, Gong Y. Essentials of Chinese Materia Medica and Medical Formulas. Academic Press/Elsevier, 2017, pp. 330–340.

Cultural and historical

Zhong Yao Zhi (Chinese Materia Medica compendium) · Modern China, entry added 1959

Pseudostellaria heterophylla is a late entrant to the Chinese materia medica rather than a classical drug. The tuberous root, under the names Tai Zi Shen and Hai Er Shen, was formally added to the modern national materia medica in 1959 on the basis of regional and folk use, and there is no entry for this species in the Han-to-Ming canon. Because the name Tai Zi Shen literally means 'prince ginseng' and the drug is used as a gentler stand-in for Ren Shen, classical quotations offered in support of it usually belong to ginseng or to some other drug and should be checked before being repeated.

References

  1. Yang Y, Wen L, Jiang ZZ, Chan BCL, Leung PC, Wong CK. Chemical Properties, Preparation, and Pharmaceutical Effects of Cyclic Peptides from Pseudostellaria heterophylla. Molecules. 2025 doi:10.3390/molecules30122521
  2. Sha M, Li X, Liu Y, Tian H, Liang X, Li X, Gao W. Comparative chemical characters of Pseudostellaria heterophylla from geographical origins of China. Chinese Herbal Medicines. 2023 doi:10.1016/j.chmed.2022.10.005
  3. Gao S, Ye K, Zhang Z, Wang W, Li J, Xu T, Tan H. Polysaccharides of Pseudostellaria heterophylla (Miq.) Pax ex Pax et Hoffm: Extraction, purification, structural characteristics, pharmacological activities, and structure–activity relationships: A review. International Journal of Biological Macromolecules. 2025 doi:10.1016/j.ijbiomac.2025.148082
  4. Li H, Wang S, Yang Z, Ma P. Advances in Pseudostellaria heterophylla Research: Current Status and Future Directions. Molecules. 2025 doi:10.3390/molecules30173656
  5. Zhang W, Xu X, Chen J, Zhao Y, Liu B, Huang Y. Differences in Chemical Components and Antioxidant Ability Analysis of Pseudostellaria heterophylla from Multiple Origins. International Journal of Molecular Sciences. 2026 doi:10.3390/ijms27073139
  6. Chen Y, Huang Y, Huang C, Zhang S, Fan M, Yuan X, Huang C, Zhang M, Peng J, Sun R, Zhang S, Chen W, Gong Z. An engineered micropatch for oral delivery of heterophyllin B in type 2 diabetes treatment. Journal of Controlled Release. 2026 doi:10.1016/j.jconrel.2026.114782
© Verscienta Health — use subject to the API terms at https://verscienta.com/developers/api; educational reference, not medical advice